5326122026-01-012026-03-315326122026-03-315326122025-03-315326122025-04-012026-03-315326122026-01-012026-03-31in-capmkt:OtherExpenses1Member5326122026-01-012026-03-31in-capmkt:OtherExpenses2Member5326122025-04-012026-03-31in-capmkt:OtherExpenses1Member5326122025-04-012026-03-31in-capmkt:OtherExpenses2Member5326122026-03-31OtherNoncurrentFinancialAssetsDomain15326122026-03-31OtherNoncurrentAssetsDomain15326122026-03-31OtherCurrentFinancialAssetsDomain15326122026-03-31OtherCurrentAssetsDomain15326122026-03-31OtherCurrentAssetsDomain25326122026-03-31OtherNoncurrentFinancialLiabilitiesDomain15326122026-03-31OtherNoncurrentFinancialLiabilitiesDomain25326122026-03-31OtherNoncurrentLiabilitiesDomain15326122026-03-31OtherCurrentFinancialLiabilitiesDomain15326122026-03-31OtherCurrentFinancialLiabilitiesDomain25326122026-03-31OtherCurrentLiabilitiesDomain15326122026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15326122025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15326122026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15326122025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15326122026-01-012026-03-31RelatedPartyTransactionDomain15326122025-12-31RelatedPartyTransactionDomain15326122026-03-31RelatedPartyTransactionDomain15326122026-01-012026-03-31RelatedPartyTransactionDomain25326122025-12-31RelatedPartyTransactionDomain25326122026-03-31RelatedPartyTransactionDomain25326122026-01-012026-03-31RelatedPartyTransactionDomain35326122025-12-31RelatedPartyTransactionDomain35326122026-03-31RelatedPartyTransactionDomain35326122026-01-012026-03-31RelatedPartyTransactionDomain45326122025-12-31RelatedPartyTransactionDomain45326122026-03-31RelatedPartyTransactionDomain45326122026-01-012026-03-31RelatedPartyTransactionDomain55326122025-12-31RelatedPartyTransactionDomain55326122026-03-31RelatedPartyTransactionDomain55326122026-01-012026-03-31RelatedPartyTransactionDomain65326122025-12-31RelatedPartyTransactionDomain65326122026-03-31RelatedPartyTransactionDomain65326122026-01-012026-03-31RelatedPartyTransactionDomain75326122025-12-31RelatedPartyTransactionDomain75326122026-03-31RelatedPartyTransactionDomain75326122026-01-012026-03-31RelatedPartyTransactionDomain85326122025-12-31RelatedPartyTransactionDomain85326122026-03-31RelatedPartyTransactionDomain85326122026-01-012026-03-31RelatedPartyTransactionDomain95326122025-12-31RelatedPartyTransactionDomain95326122026-03-31RelatedPartyTransactionDomain95326122026-01-012026-03-31RelatedPartyTransactionDomain105326122025-12-31RelatedPartyTransactionDomain105326122026-03-31RelatedPartyTransactionDomain105326122026-01-012026-03-31RelatedPartyTransactionDomain115326122025-12-31RelatedPartyTransactionDomain115326122026-03-31RelatedPartyTransactionDomain115326122026-01-012026-03-31RelatedPartyTransactionDomain125326122025-12-31RelatedPartyTransactionDomain125326122026-03-31RelatedPartyTransactionDomain125326122026-01-012026-03-31RelatedPartyTransactionDomain135326122025-12-31RelatedPartyTransactionDomain135326122026-03-31RelatedPartyTransactionDomain135326122026-01-012026-03-31RelatedPartyTransactionDomain145326122025-12-31RelatedPartyTransactionDomain145326122026-03-31RelatedPartyTransactionDomain145326122026-01-012026-03-31RelatedPartyTransactionDomain155326122025-12-31RelatedPartyTransactionDomain155326122026-03-31RelatedPartyTransactionDomain155326122026-01-012026-03-31RelatedPartyTransactionDomain165326122025-12-31RelatedPartyTransactionDomain165326122026-03-31RelatedPartyTransactionDomain165326122026-01-012026-03-31RelatedPartyTransactionDomain175326122025-12-31RelatedPartyTransactionDomain175326122026-03-31RelatedPartyTransactionDomain175326122026-01-012026-03-31RelatedPartyTransactionDomain185326122025-12-31RelatedPartyTransactionDomain185326122026-03-31RelatedPartyTransactionDomain185326122026-01-012026-03-31RelatedPartyTransactionDomain195326122025-12-31RelatedPartyTransactionDomain195326122026-03-31RelatedPartyTransactionDomain195326122026-01-012026-03-31RelatedPartyTransactionDomain205326122025-12-31RelatedPartyTransactionDomain205326122026-03-31RelatedPartyTransactionDomain205326122026-01-012026-03-31RelatedPartyTransactionDomain215326122025-12-31RelatedPartyTransactionDomain215326122026-03-31RelatedPartyTransactionDomain215326122026-01-012026-03-31RelatedPartyTransactionDomain225326122025-12-31RelatedPartyTransactionDomain225326122026-03-31RelatedPartyTransactionDomain225326122026-01-012026-03-31RelatedPartyTransactionDomain235326122025-12-31RelatedPartyTransactionDomain235326122026-03-31RelatedPartyTransactionDomain235326122026-01-012026-03-31RelatedPartyTransactionDomain245326122025-12-31RelatedPartyTransactionDomain245326122026-03-31RelatedPartyTransactionDomain245326122026-01-012026-03-31RelatedPartyTransactionDomain255326122025-12-31RelatedPartyTransactionDomain255326122026-03-31RelatedPartyTransactionDomain255326122026-01-012026-03-31RelatedPartyTransactionDomain265326122025-12-31RelatedPartyTransactionDomain265326122026-03-31RelatedPartyTransactionDomain265326122026-01-012026-03-31RelatedPartyTransactionDomain275326122025-12-31RelatedPartyTransactionDomain275326122026-03-31RelatedPartyTransactionDomain275326122026-01-012026-03-31RelatedPartyTransactionDomain285326122025-12-31RelatedPartyTransactionDomain285326122026-03-31RelatedPartyTransactionDomain285326122026-01-012026-03-31RelatedPartyTransactionDomain295326122025-12-31RelatedPartyTransactionDomain295326122026-03-31RelatedPartyTransactionDomain295326122026-01-012026-03-31RelatedPartyTransactionDomain305326122025-12-31RelatedPartyTransactionDomain305326122026-03-31RelatedPartyTransactionDomain305326122026-01-012026-03-31RelatedPartyTransactionDomain315326122025-12-31RelatedPartyTransactionDomain315326122026-03-31RelatedPartyTransactionDomain315326122026-01-012026-03-31RelatedPartyTransactionDomain325326122025-12-31RelatedPartyTransactionDomain325326122026-03-31RelatedPartyTransactionDomain325326122026-01-012026-03-31RelatedPartyTransactionDomain335326122025-12-31RelatedPartyTransactionDomain335326122026-03-31RelatedPartyTransactionDomain335326122026-01-012026-03-31RelatedPartyTransactionDomain345326122025-12-31RelatedPartyTransactionDomain345326122026-03-31RelatedPartyTransactionDomain345326122026-01-012026-03-31RelatedPartyTransactionDomain355326122025-12-31RelatedPartyTransactionDomain355326122026-03-31RelatedPartyTransactionDomain355326122026-01-012026-03-31RelatedPartyTransactionDomain365326122025-12-31RelatedPartyTransactionDomain365326122026-03-31RelatedPartyTransactionDomain365326122026-01-012026-03-31RelatedPartyTransactionDomain375326122025-12-31RelatedPartyTransactionDomain375326122026-03-31RelatedPartyTransactionDomain375326122026-01-012026-03-31RelatedPartyTransactionDomain385326122025-12-31RelatedPartyTransactionDomain385326122026-03-31RelatedPartyTransactionDomain385326122026-01-012026-03-31RelatedPartyTransactionDomain395326122025-12-31RelatedPartyTransactionDomain395326122026-03-31RelatedPartyTransactionDomain395326122026-01-012026-03-31RelatedPartyTransactionDomain405326122025-12-31RelatedPartyTransactionDomain405326122026-03-31RelatedPartyTransactionDomain405326122026-01-012026-03-31RelatedPartyTransactionDomain415326122025-12-31RelatedPartyTransactionDomain415326122026-03-31RelatedPartyTransactionDomain415326122026-01-012026-03-31RelatedPartyTransactionDomain425326122025-12-31RelatedPartyTransactionDomain425326122026-03-31RelatedPartyTransactionDomain425326122026-01-012026-03-31RelatedPartyTransactionDomain435326122025-12-31RelatedPartyTransactionDomain435326122026-03-31RelatedPartyTransactionDomain435326122026-01-012026-03-31RelatedPartyTransactionDomain445326122025-12-31RelatedPartyTransactionDomain445326122026-03-31RelatedPartyTransactionDomain445326122026-01-012026-03-31RelatedPartyTransactionDomain455326122025-12-31RelatedPartyTransactionDomain455326122026-03-31RelatedPartyTransactionDomain455326122026-01-012026-03-31RelatedPartyTransactionDomain465326122025-12-31RelatedPartyTransactionDomain465326122026-03-31RelatedPartyTransactionDomain465326122026-01-012026-03-31RelatedPartyTransactionDomain475326122025-12-31RelatedPartyTransactionDomain475326122026-03-31RelatedPartyTransactionDomain475326122026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares532612INDOCONOTLISTEDINE873D01024INDOCO REMEDIES LIMITEDMain BoardEquity2025-04-012026-03-312026-05-072026-04-27INRLakhsQuarterlyFourth quarterSingle segmentPHARMACEUTICALS2026-05-0711:05:002026-05-0712:30:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-03-25https://www.indoco.com/policies/Policy_on_Materiality_of_Related_Party_Transactions_March2025.pdffalsefalseThe Company does not have any debt securities and there are no defaults on loan taken by the Company for the quarter and year ended 31st March, 2026. Hence the said disclosure is not applicable to the Company.2026-01-012026-03-31AuditedStandalone449130000010350000045948000009825000002908000001058000001009800000227300000267100000147210000043554000002394000003680000027620000029200000-26500000270000002735000000000273500000500000027850000018460000022.962.96002.962.961. The audited Standalone Results for the Quarter and Year ended 31st March, 2026 have been reviewed by the Audit committee and approved by the Board of Directors of the Company at its meeting held on 07th May, 2026. The Statutory Auditors have expressed an Unmodified Audit opinion on these audited Standalone Financial Results. <BR> <BR> 2. The figures for corresponding previous periods have been restated / regrouped wherever necessary, to make them comparable. <BR> <BR> 3. The Board of Directors have proposed, subject to the approval of shareholders in the ensuing Annual General Meeting a Dividend of 10% i.e. 0.20 per equity share on face value of Rs. 2/-each to its equity shareholder's for the year 2025-2026. <BR> <BR> 4.In Nomination and Remuneration Committee meeting held on 03rd February 2026, the Company has allotted 55,700 number of equity shares to Indoco Employees Welfare Trust under Indoco Remedies Limited Employee Stock Option Plan-2022. <BR> <BR> 5.The company has only one primary reportable segment of activity, namely, Pharmaceuticals. <BR> <BR> 6. Net Sales and Income from Operations as per Secondary Segment (Geographical) is as follows: <BR> (Rs. in lakhs) <BR> -------------------------------------------------------------------------------------------------------------------------------- <BR> <BR> Net Sales Qtr ended Qtr ended Qtr ended Year ended Year ended <BR> & Income 31-03-2026 31-12-2025 31-03-2025 31-03-2026 31-03-2025 <BR> from Operations (Audited) (Unaudited) (Audited) (Audited) (Audited) <BR> ---------------------------------------------------------------------------------------------------------------------------------- <BR> <BR> India 19,363 23,060 21,639 89,413 91,598 <BR> Outside India 23,543 15,897 12,468 73,941 57,880 <BR> --------------------------------------------------------------------------------------------------------------------------------- <BR> Total : 42,906 38,957 34,107 1,63,354 1,49,478 <BR> ================================================================= <BR> <BR> 7. Figures for the quarter ended 31.3.2026 and 31.3.2025 represents the difference between audited figures in respect of the full financial year and published figures for the period ended 31.12.2025 (limited reviewed) and 31.12.2024 (limited reviewed). <BR> <BR> 8. (*) Exceptional items during the year includes : (a) Consideration received Rs. 346 lakhs for grant to use exclusive, perpetual and irrevocable license rights in respect of trademarks of the company, <BR> (b) Loss amounting to Rs. 213 lakhs on sale and leaseback of its Non current Assets, and, <BR> (c) Impact of past period employee benefit liability amounting to Rs. 419 lakhs due to implementation of the New Labour Codes. <BR> <BR> 9. Effective 21" November, 2025, The Government of India has consolidated multiple existing labour legislations into a unified framework comprising four Labour Codes collectively referred to as the 'New Labour Codes'. The Company has assessed the financial implications of these changes which has resulted in increase in gratuity liability arising out of past service cost and increase in leave liability by Rs. 419 lakhs primarily arising due to change in definition of "wages" for employees and contract labours. Considering the materiality and nonrecurring nature of this impact, the Company has presented such incremental impact under 'Exceptional Item" in the standalone financial results for the year ended 31st March, 2026. The Company continues to monitor the developments pertaining to the New Labour Codes and the impact, if any, will be accounted in accordance with applicable accounting standards.2025-04-012026-03-31AuditedStandalone1686070000029640000017157100000353230000014012000007200000039363000008850000001069000000634740000017243200000-86100000-28600000-11470000029200000-87300000-581000000-566000000000-5660000013300000-43300000184600000210807300000-0.61-0.6100-0.61-0.61Research & Development Expense177600000Other Expenses1294500000Research & Development Expense795400000Other Expenses5552000000703460000023490000001479900000617200000159750000050560000078600000218170000096550000012513800000321830000005412000000129400000706000004560000035590000060135000002136000001691800000111372000002365100000018460000010807300000109919000001099190000030161000004509000003467000000346800000157000007490000039044000004039900000818400000178710000026055000001078500000772390000056670000046410000087547000001265910000023651000000Other Financial Assets78600000Other Non-Current Assets965500000Other Financial Assets355900000Other Current Assets1457700000Assets Classified as held for Sale234100000Lease Liabilities423400000Other Financial Liabilities27500000Other Non-Current Liabilities74900000Lease Liabilities115600000Other Financial Liabilities962900000Other Current Liabilities566700000885000000410300000-17107000000-98100000-155300000-15200000-444000000113190000003443000000106900000001350000015700000239600000477600000-9240000001768000006000000000131500000600000002437500000232280000000059300000022635000000107790000000000044260000012535000000000000000000680000009270000000001769000000-20900000-8738000000013000000000005300000008538000001096000001910000089140000000-13309000005880000005880000070600000129400000Items that will not be reclassified to profit and loss4030000040300000Items that will not be reclassified to profit and loss1780000017800000102000004500000Items that may be reclassified to profit or loss-33500000-33500000Items that may be reclassified to profit or loss00-84000000500000013300000INDOCO REMEDIES LIMITED******Suresh Govind Kare- HUF******PromoterAny other transactionPayment of Godown Rent750000NA15000000INDOCO REMEDIES LIMITED******A K Services & Agency Private Limited (Formerly known as A. K. Services)******Mrs. Aditi Panandikar Managing Director of the Company is the Director of A K Services & Agency Private LimitedPurchase of goods or services30000000NA64380007970003637000The details mentioned in this row is pertaining to Purchase of ServicesINDOCO REMEDIES LIMITED******A K Services & Agency Private Limited (Formerly known as A. K. Services)******Mrs. Aditi Panandikar Managing Director of the Company is the Director of A K Services & Agency Private LimitedPurchase of goods or services7500000NA1080000180000418000The details mentioned in this row is pertaining to Purchase of ServicesINDOCO REMEDIES LIMITED******A K Services & Agency Private Limited (Formerly known as A. K. Services)******Mrs. Aditi Panandikar Managing Director of the Company is the Director of A K Services & Agency Private LimitedInterest paid200000NA370003800068000INDOCO REMEDIES LIMITED******A K Services & Agency Private Limited (Formerly known as A. K. Services)******Mrs. Aditi Panandikar Managing Director of the Company is the Director of A K Services & Agency Private LimitedAny other transactionRent Received240000NA12000000INDOCO REMEDIES LIMITED******Xtend Industrial Designers and Engineers Pvt. Ltd.******Wholly Owned SubsidiaryPurchase of goods or services75000000NA197700010180001146000The details mentioned in this row is pertaining to Purchase of ServicesINDOCO REMEDIES LIMITED******Xtend Industrial Designers and Engineers Pvt. Ltd.******Wholly Owned SubsidiaryAny other transactionReimbursable Expenses towards ESOP Compensation CostNA-43500081000-354000INDOCO REMEDIES LIMITED******Florida Pharmaceutical Products, LLC******Step Down SubsidiaryAny other transactionProviding of corporate guarantee in favour of bank in connection with loan taken by Florida Pharmaceutical Products, LLC700000000NA0170000000170000000INDOCO REMEDIES LIMITED******Florida Pharmaceutical Products, LLC******Step Down SubsidiarySale of goods or services5000000NA39400013980001792000The details mentioned in this row is pertaining to Sale of ServicesINDOCO REMEDIES LIMITED******Florida Pharmaceutical Products, LLC******Step Down SubsidiarySale of goods or services750000000NA472442000517976000927624000The details mentioned in this row is pertaining to Sale of ProductsINDOCO REMEDIES LIMITED******FPP Holding Company, LLC******SubsidiaryLoan700000000NA29950000443925000473875000The details mentioned in this row is pertaining to revaluation of existing ICD loan given to FPP Holding Company, LLCINDOCO REMEDIES LIMITED******FPP Holding Company, LLC******SubsidiaryAny other transactionInterest receivable on ICD Loan providedNA135070006104300074551000INDOCO REMEDIES LIMITED******Suresh Govind Kare******(Chairman & Non Executive Director) & PromoterAny other transactionPayment of Sitting FeesNA8000000INDOCO REMEDIES LIMITED******Aditi Panandikar******Key Management Personnel (MD) & PromoterRemunerationNA3454800000INDOCO REMEDIES LIMITED******Sundeep V Bambolkar******Key Management Personnel (Jt. MD)RemunerationNA3076500000INDOCO REMEDIES LIMITED******Ramanathan Hariharan******Key Management Personnel (CS)RemunerationNA336200000INDOCO REMEDIES LIMITED******Pramod Ghorpade******Key Management Personnel (CFO)RemunerationNA948300000INDOCO REMEDIES LIMITED******Madhura Suresh Kare******PromoterRemunerationThe Audit Committee has approved maximum limit of Rs. 1 crore per annum for remuneration payable to Ms. Madhura Suresh Kare293700000INDOCO REMEDIES LIMITED******Satish Shenoy******Independent DirectorAny other transactionPayment of Sitting FeesNA28000000INDOCO REMEDIES LIMITED******Ajay Mulgaokar******Independent DirectorAny other transactionPayment of Sitting FeesNA32000000INDOCO REMEDIES LIMITED******Vasudha Kamat******Independent DirectorAny other transactionPayment of Sitting FeesNA28000000INDOCO REMEDIES LIMITED******Abhijit Gore******Independent DirectorAny other transactionPayment of Sitting FeesNA32000000INDOCO REMEDIES LIMITED******Anand Nadkarni******Non Executive and Non Independent DirectorAny other transactionPayment of Sitting FeesNA18000000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryLoan1000000000NA-9270000009270000000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryLoan2000000000NA106500000000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryInterest receivedNA445800001203240000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryAny other transactionProviding of Corporate Guarantee in favour of bank in connection with loan taken by Warren Remedies Private Limited3000000000NA25000000023950000002645000000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryAny other transactionCommission on Corporate Guarantee ReceivableNA236440006386200010023000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryAny other transactionInterest on corporate guarantee receivableNA403500070370002011000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiarySale of goods or services10000000NA682300096830008703000This details mentioned in this row is pertaining to Sale of ProductsINDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryPurchase of goods or services450000000NA633380003151500025460000The details mentioned in this row is pertaining to Purchase of Products including Finished Goods, RM, PM reimbursement Loan License, raw material, packing material, toolsINDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiarySale of fixed assets150000000NA15700024016000185000This details mentioned in this row is pertaining to Sale of AssetsINDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryPurchase of fixed assets100000000NA42000050000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiarySale of goods or services50000000NA642500065700006939000The details mentioned in this row is pertaining to Sale of ServicesINDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryPurchase of goods or services80000000NA29190006170002038000The details mentioned in this row is pertaining to Purchase of ServicesINDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryAny other transactionLicensing of Brand by Indoco18600000NA18600000263470000254762000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryAny other transactionReimbursable Expenses towards ESOP Compensation CostNA5070006240001131000Xtend Industrial Designers and Engineers Pvt. Ltd.******Warren Remedies Private Limited******Mrs. Aditi Panandikar & Mr. Sundeep V Bambolkar, Directors of Xtend Industrial Designers and Engineers Pvt. Ltd. are Directors of Warren Remedies Pvt. Ltd.LoanNA150000004000000055000000Xtend Industrial Designers and Engineers Pvt. Ltd.******Warren Remedies Private Limited******Mrs. Aditi Panandikar & Mr. Sundeep V Bambolkar, Directors of Xtend Industrial Designers and Engineers Pvt. Ltd. are Directors of Warren Remedies Pvt. Ltd.Interest receivedNA211100016710003782000Warren Remedies Private Limited******Suresh Govind Kare******DirectorLoan150000000NA1500000000150000000Warren Remedies Private Limited******Suresh Govind Kare******DirectorInterest receivedNA256700000Warren Remedies Private Limited******Aditi Panandikar******DirectorLoanNA95000000095000000Warren Remedies Private Limited******Aditi Panandikar******DirectorInterest receivedNA204000000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryAny other transactionGratuity obligation of employees transfered from Indoco Remedies Ltd. to Warren Remedies Pvt. Ltd.NA068410000INDOCO REMEDIES LIMITED******Warren Remedies Private Limited******Wholly Owned SubsidiaryAny other transactionInterest overdue on brand licensing by IndocoNA147020002334700034244000INDOCO REMEDIES LIMITED******Florida Pharmaceutical Products, LLC******Step Down SubsidiaryAny other transactionCommission receivable on Corporate Guarantee providedNA415900004159000Warren Remedies Private Limited******Ulhas Anant Joshi******DirectorAny other transactionConsultancy Fees paidNA980000001453844000AuditedtrueM/s. Gokhale & Sathetrue2027-02-28